Cinnamomum cassia is used as a flavoring spice with some established medici
nal properties. In this study, we evaluated the antimutagenic effect of C.
cassia against two mutagens, viz. benzo[a]pyrene (B[a]P) and cyclophosphami
de (CP). The antimutagenic properties of C cassia were examined by the Ames
test. In vivo chromosomal aberration (CA) and micronuclei tests were also
employed to assess the antimutagenic effect of C. cassia in mice after pret
reatment with the extract orally for seven consecutive days. To elucidate t
he mechanism by which C. cassia exerts its antimutagenic effect, certain ke
y enzymes involved in bioactivation and detoxification processes were also
investigated. Changes in liver cytochrome P450 (Cyt P450), glutathione cont
ent (GSH), glutathione S-transferase (GST), glutathione reductase (GR), and
glutathione peroxidase (GPX) were evaluated in pretreated animals. It was
observed in the Ames test, bone marrow chromosomal aberration assay, and mi
cronucleus test that C cassia exerted significant antimutagenic effects aga
inst B[a]P and CP in animals treated with the plant extract. C cassia pretr
eatment decreased Cyt P450 content but increased GSH content and the activi
ty of glutathione-de pendent antioxidant enzymes, viz. GST, GR, and GPX. Th
e present findings demonstrate that the antimutagenic potential of C. cassi
a could be attributed to its modulatory effect on the xenobiotic bioactivat
ion and detoxification processes. (C) 2001 Elsevier Science B.V. All rights
reserved.